{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:05:00Z","timestamp":1783019100348,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Mitochondrial diseases present as multi-system disorders requiring a comprehensive multidisciplinary approach. The data on healthcare resource utilization associated with mitochondrial diseases and the clinical drivers of these costs are limited including for the out-patient setting where the majority of the clinical care for mitochondrial disease patients occurs. We performed a cross-sectional retrospective study of out-patient healthcare resource utilization and costs for patients with a confirmed diagnosis of mitochondrial disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited participants from the Mitochondrial Disease Clinic in Sydney and stratified them into three groups: those with mitochondrial DNA (mtDNA) mutations (Group 1), those with nuclear DNA (nDNA) mutations and the predominant phenotype of chronic progressive external ophthalmoplegia (CPEO) or optic atrophy (Group 2) and those without a confirmed genetic diagnosis but clinical criteria and muscle biopsy findings supportive of a diagnosis of mitochondrial disease (Group 3). Data was collected through retrospective chart review and out-patient costs were calculated using the Medicare Benefits Schedule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analyzed the data from 91 participants and found that Group 1 had the greatest average out-patient costs per person per annum ($838.02; SD 809.72). Neurological investigations were the largest driver of outpatient healthcare costs in all groups (average costs per person per annum:\u2014Group 1: $364.11; SD 340.93, Group 2: $247.83; SD 113.86 and Group 3: $239.57; SD 145.69) consistent with the high frequency (94.5%) of neurological symptoms. Gastroenterological and cardiac-related out-patient costs were also major contributors to out-patient healthcare resource utilization in Groups 1 and 3. In Group 2, ophthalmology was the second-most resource intensive specialty ($136.85; SD 173.35). The Group 3 had the greatest average healthcare resource utilization per person over the entire duration of out-patient clinic care ($5815.86; SD 3520.40) most likely due to the lack of a molecular diagnosis and a less customized management approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The drivers of healthcare resource utilization are dependent on the phenotype\u2013genotype characteristics. Neurological, cardiac, and gastroenterological costs were the top three drivers in the out-patient clinics unless the patient had nDNA mutations with predominant phenotype of CPEO and\/or optic atrophy wherein ophthalmological-related costs were the second most resource intensive driver.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02746-x","type":"journal-article","created":{"date-parts":[[2023,5,28]],"date-time":"2023-05-28T21:02:00Z","timestamp":1685307720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-6640","authenticated-orcid":false,"given":"Sameen","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupendra","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"issue":"7","key":"2746_CR1","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1212\/WNL.0000000000200745","volume":"99","author":"RL Davis","year":"2022","unstructured":"Davis RL, Raj R, Kumar K, Puttick C, Liang C, Ahmad KE, Edema-Hildebrand F, Park JS, Minoche AE, Gayevskiy V, Mallawaarachchi AC, Christodoulou J, Schofield D, Dinger ME, Cowley MJ, Sue CM. Use of whole-genome sequencing for mitochondrial disease diagnosis. Neurology. 2022;99(7):e730\u201342.","journal-title":"Neurology"},{"issue":"7","key":"2746_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","volume":"20","author":"YS Ng","year":"2021","unstructured":"Ng YS, Bindoff LA, Gorman GS, et al. Mitochondrial disease in adults: recent advances and future promise. Lancet neurol. 2021;20(7):573\u201384.","journal-title":"Lancet neurol"},{"issue":"6","key":"2746_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/joim.13064","volume":"287","author":"C La Morgia","year":"2020","unstructured":"La Morgia C, Maresca A, Caporali L, Valentino ML, Carelli V. Mitochondrial diseases in adults. J Intern Med. 2020;287(6):592\u2013608.","journal-title":"J Intern Med"},{"issue":"44","key":"2746_CR4","first-page":"741","volume":"118","author":"T Klopstock","year":"2021","unstructured":"Klopstock T, Priglinger C, Yilmaz A, Kornblum C, Distelmaier F, Prokisch H. Mitochondrial disorders. Dtsch Arztebl int. 2021;118(44):741\u20138.","journal-title":"Dtsch Arztebl int"},{"key":"2746_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-63233-3.00010-5","volume":"147","author":"RL Davis","year":"2018","unstructured":"Davis RL, Liang C, Sue CM. Mitochondrial diseases. Handb Clin Neurol. 2018;147:125\u201341.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"2746_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.bbagen.2013.10.040","volume":"1840","author":"C Liang","year":"2014","unstructured":"Liang C, Ahmad K, Sue CM. The broadening spectrum of mitochondrial disease: shifts in the diagnostic paradigm. Biochim Biophys Acta. 2014;1840(4):1360\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"2746_CR7","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman GS, Chinnery PF, DiMauro S, et al. Mitochondrial diseases. Nat Rev Dis Prim. 2016;2:16080.","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"2746_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/imj.15505","volume":"52","author":"CM Sue","year":"2022","unstructured":"Sue CM, Balasubramaniam S, Bratkovic D, et al. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations. Intern Med J. 2022;52(1):110\u201320.","journal-title":"Intern Med J"},{"issue":"12","key":"2746_CR9","first-page":"1380","volume":"19","author":"S Parikh","year":"2017","unstructured":"Parikh S, Goldstein A, Karaa A, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017;19(12):1380.","journal-title":"Genet Med"},{"issue":"8","key":"2746_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S1474-4422(10)70116-2","volume":"9","author":"R McFarland","year":"2010","unstructured":"McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet neurol. 2010;9(8):829\u201340.","journal-title":"Lancet neurol"},{"issue":"4","key":"2746_CR11","first-page":"385","volume":"40","author":"DE Meyers","year":"2013","unstructured":"Meyers DE, Basha HI, Koenig MK. Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J. 2013;40(4):385\u201394.","journal-title":"Tex Heart Inst J"},{"issue":"11","key":"2746_CR12","first-page":"887","volume":"20","author":"Y Guo","year":"2018","unstructured":"Guo Y, Hong SQ, Jiang L. An interpretation of the expert consensus on standards for the management of patients with primary mitochondrial disease from the Mitochondrial Medicine Society. Zhongguo Dang Dai Er Ke Za Zhi. 2018;20(11):887\u201392.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"2746_CR13","unstructured":"https:\/\/www.aihw.gov.au\/getmedia\/9844cefb-7745-4dd8-9ee2-f4d1c3d6a727\/19787-AH16.pdf.aspx."},{"key":"2746_CR14","first-page":"64","volume-title":"Caring for people with chronic conditions: a health system perspective","author":"E Nolte","year":"2008","unstructured":"Nolte E, McKee M. Integration and chronic care: a review. In: Nolte E, McKee M, editors. Caring for people with chronic conditions: a health system perspective. Maidenhead: Open University Press; 2008. p. 64\u201391."},{"key":"2746_CR15","unstructured":"https:\/\/apps.who.int\/iris\/handle\/10665\/42500."},{"issue":"1","key":"2746_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13023-018-0949-5","volume":"13","author":"B Cohen","year":"2018","unstructured":"Cohen B, Balcells C, Hotchkiss B, Aggarwal K, Karaa A. A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008\u20132015. Orphanet J Rare Dis. 2018;13(1):210.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2746_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265744","volume":"17","author":"E Buajitti","year":"2022","unstructured":"Buajitti E, Rosella LC, Zabzuni E, Young LT, Andreazza AC. Prevalence and health care costs of mitochondrial disease in Ontario, Canada: a population-based cohort study. PLoS ONE. 2022;17(4): e0265744.","journal-title":"PLoS ONE"},{"issue":"10","key":"2746_CR18","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","volume":"67","author":"E Morava","year":"2006","unstructured":"Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology. 2006;67(10):1823\u20136.","journal-title":"Neurology"},{"key":"2746_CR19","unstructured":"https:\/\/www.nhmrc.gov.au\/about-us\/publications\/national-statement-ethical-conduct-human-research-2007-updated-2018."},{"key":"2746_CR20","unstructured":"https:\/\/www1.health.nsw.gov.au\/pds\/ActivePDSDocuments\/PD2010_055.pdf."},{"issue":"4","key":"2746_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10545-017-0027-5","volume":"40","author":"C Viscomi","year":"2017","unstructured":"Viscomi C, Zeviani M. MtDNA-maintenance defects: syndromes and genes. J Inherit Metab Dis. 2017;40(4):587\u201399.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2746_CR22","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1212\/NXG.0000000000000230","volume":"4","author":"J Grier","year":"2018","unstructured":"Grier J, Hirano M, Karaa A, Shepard E, Thompson JLP. Diagnostic odyssey of patients with mitochondrial disease: results of a survey. Neurol Genet. 2018;4(2):e230.","journal-title":"Neurol Genet."},{"issue":"12","key":"2746_CR23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/bjo.2008.144816","volume":"92","author":"J Ahn","year":"2008","unstructured":"Ahn J, Kim NJ, Choung HK, et al. Frontalis sling operation using silicone rod for the correction of ptosis in chronic progressive external ophthalmoplegia. Br J Ophthalmol. 2008;92(12):1685\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2746_CR24","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1177\/1120672120952344","volume":"31","author":"M Eshaghi","year":"2021","unstructured":"Eshaghi M, Arabi A, Eshaghi S. Surgical management of ptosis in chronic progressive external ophthalmoplegia. Eur J Ophthalmol. 2021;31(4):2064\u20138.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2746_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/01676830.2012.736599","volume":"32","author":"M Doherty","year":"2013","unstructured":"Doherty M, Winterton R, Griffiths PG. Eyelid surgery in ocular myopathies. Orbit. 2013;32(1):12\u20135.","journal-title":"Orbit"},{"issue":"11","key":"2746_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/qjmed\/90.11.657","volume":"90","author":"PF Chinnery","year":"1997","unstructured":"Chinnery PF, Turnbull DM. Mitochondrial medicine. QJM. 1997;90(11):657\u201367.","journal-title":"QJM"},{"issue":"8","key":"2746_CR27","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1001\/archneurol.2010.174","volume":"67","author":"T Parsons","year":"2010","unstructured":"Parsons T, Weimer L, Engelstad K, et al. Autonomic symptoms in carriers of the m3243A>G mitochondrial DNA mutation. Arch Neurol. 2010;67(8):976\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"2746_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.gastro.2009.03.054","volume":"137","author":"A Amiot","year":"2009","unstructured":"Amiot A, Tchikviladze M, Joly F, et al. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology. 2009;137(1):101\u20139.","journal-title":"Gastroenterology"},{"issue":"5\u20136","key":"2746_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.mito.2004.07.014","volume":"4","author":"XB Hom","year":"2004","unstructured":"Hom XB, Lavine JE. Gastrointestinal complications of mitochondrial disease. Mitochondrion. 2004;4(5\u20136):601\u20137.","journal-title":"Mitochondrion"},{"issue":"42","key":"2746_CR30","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1093\/eurheartj\/ehv307","volume":"36","author":"K Wahbi","year":"2015","unstructured":"Wahbi K, Bougouin W, Behin A, et al. Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases. Eur Heart J. 2015;36(42):2886\u201393.","journal-title":"Eur Heart J"},{"key":"2746_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","volume":"181","author":"P Kabunga","year":"2015","unstructured":"Kabunga P, Lau AK, Phan K, et al. Systematic review of cardiac electrical disease in Kearns\u2013Sayre syndrome and mitochondrial cytopathy. Int J Cardiol. 2015;181:303\u201310.","journal-title":"Int J Cardiol"},{"issue":"24","key":"2746_CR32","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","volume":"33","author":"MG Bates","year":"2012","unstructured":"Bates MG, Bourke JP, Giordano C, d\u2019Amati G, Turnbull DM, Taylor RW. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J. 2012;33(24):3023\u201333.","journal-title":"Eur Heart J"},{"issue":"1\u20132","key":"2746_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ymgme.2019.09.003","volume":"128","author":"RM Boggan","year":"2019","unstructured":"Boggan RM, Lim A, Taylor RW, McFarland R, Pickett SJ. Resolving complexity in mitochondrial disease: towards precision medicine. Mol Genet Metab. 2019;128(1\u20132):19\u201329.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02746-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T09:05:08Z","timestamp":1685351108000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02746-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02746-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2525750\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Methods section in the manuscript includes North Sydney Local Health District Human Research Ethics Committee (NSLHD-HREC) approval reference number (LNR\/17\/HAWKE\/268) in accordance with National Health and Medical Research Council (NHMRC) National Statement and NSW Health Policy Directive. The principal author has received consent forms from the participants in this study and has them on file.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As indicated above in the section: Ethics approval and Consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no disclosures relative to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}